Semin Thromb Hemost 2018; 44(08): 747-755
DOI: 10.1055/s-0038-1667115
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prothrombotic State Induced by Middle-Distance Endurance Exercise in Middle-Aged Athletes

Giuseppe Lippi*
1   Section of Clinical Biochemistry; Department of Neurological, Biomedical and Movement Sciences; University of Verona, Verona, Italy
,
Gian Luca Salvagno*
1   Section of Clinical Biochemistry; Department of Neurological, Biomedical and Movement Sciences; University of Verona, Verona, Italy
,
Cantor Tarperi*
2   School of Sport and Exercise Sciences; Department of Neurological, Biomedical and Movement Sciences; University of Verona, Verona, Italy
,
Matteo Gelati
1   Section of Clinical Biochemistry; Department of Neurological, Biomedical and Movement Sciences; University of Verona, Verona, Italy
,
Martina Montagnana
1   Section of Clinical Biochemistry; Department of Neurological, Biomedical and Movement Sciences; University of Verona, Verona, Italy
,
Elisa Danese
1   Section of Clinical Biochemistry; Department of Neurological, Biomedical and Movement Sciences; University of Verona, Verona, Italy
,
Luca Festa
2   School of Sport and Exercise Sciences; Department of Neurological, Biomedical and Movement Sciences; University of Verona, Verona, Italy
,
Fabian Sanchis-Gomar
3   Department of Physiology, Faculty of Medicine, University of Valencia and Fundación Investigación Hospital Clínico Universitario de Valencia, Instituto de Investigación INCLIVA, Valencia, Spain
4   Leon H. Charney Division of Cardiology, New York University School of Medicine, New York
,
Emmanuel J. Favaloro#
5   Department of Clinical and Laboratory Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, NSW Australia
,
Federico Schena#
2   School of Sport and Exercise Sciences; Department of Neurological, Biomedical and Movement Sciences; University of Verona, Verona, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
17 August 2018 (online)

Abstract

Since the impact of possible prothrombotic factors on blood coagulation resulting from exercise remains elusive, this study investigated the acute effects of middle-distance endurance running on blood coagulation parameters in middle-aged athletes. The study population consisted of 33 male endurance runners who were engaged in a 21.1 km run under competitive conditions. Blood samples were collected before the run, immediately after the run, and 3 hours after run completion. Samples were assessed for activated partial thromboplastin time (APTT), prothrombin time (PT), fibrinogen, D-dimer, factor VIII (FVIII), von Willebrand factor antigen (VWF:Ag), endogenous thrombin potential (area under the curve of thrombin generation [TGA-AUC]), and peak thrombin generation (TGA-PK). Post-run variations were expressed as delta (Δ). At baseline, APTT was found to be significantly associated with ABO blood group, VWF:Ag, and FVIII; fibrinogen with age; VWF:Ag with BMI, training regimen, and ABO blood group; APTT with FVIII; FVIII with VWF:Ag and ABO blood group; APTT with VWF:Ag; and TGA-PK with ABO blood group, PT, and TGA-AUC. Immediately after the run, statistically significant increases were observed for PT, D-dimer, VWF:Ag, and FVIII, while statistically significant reductions could be observed for APTT, TGA-AUC, and TGA-PK. Fibrinogen values remained unchanged. Significant correlations were observed between Δ VWF:Ag and Δ FVIII, Δ APTT and Δ VWF:Ag, Δ APTT and Δ FVIII, Δ TGA-AUC and Δ TGA-PK, and between Δ D-dimer and Δ TGA-AUC and Δ TGA-PK. No Δ variation was associated with running time. The results of this study seemingly suggest that middle-distance competitive running may evoke several prothrombotic changes in blood coagulation.

* These authors contributed equally to this work.


# These authors have equal senior authorship on this work.


 
  • References

  • 1 Vina J, Sanchis-Gomar F, Martinez-Bello V, Gomez-Cabrera MC. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol 2012; 167 (01) 1-12
  • 2 Reiner M, Niermann C, Jekauc D, Woll A. Long-term health benefits of physical activity--a systematic review of longitudinal studies. BMC Public Health 2013; 13: 813
  • 3 Thijssen DHJ, Redington A, George KP, Hopman MTE, Jones H. Association of exercise preconditioning with immediate cardioprotection: a review. JAMA Cardiol 2018; 3 (02) 169-176
  • 4 Garatachea N, Santos-Lozano A, Sanchis-Gomar F. , et al. Elite athletes live longer than the general population: a meta-analysis. Mayo Clin Proc 2014; 89 (09) 1195-1200
  • 5 Santos-Lozano A, Pareja-Galeano H, Sanchis-Gomar F. , et al. Physical activity and Alzheimer disease: a protective association. Mayo Clin Proc 2016; 91 (08) 999-1020
  • 6 Brown JC, Winters-Stone K, Lee A, Schmitz KH. Cancer, physical activity, and exercise. Compr Physiol 2012; 2 (04) 2775-2809
  • 7 Borch KH, Hansen-Krone I, Braekkan SK. , et al. Physical activity and risk of venous thromboembolism. The Tromso study. Haematologica 2010; 95 (12) 2088-2094
  • 8 Kahn SR, Shrier I, Kearon C. Physical activity in patients with deep venous thrombosis: a systematic review. Thromb Res 2008; 122 (06) 763-773
  • 9 Harvey Jr JS. Effort thrombosis in the lower extremity of a runner. Am J Sports Med 1978; 6 (06) 400-402
  • 10 Mackie JW, Webster JA. Deep vein thrombosis in marathon runners. Phys Sportsmed 1981; 9 (05) 91-96
  • 11 Ali MS, Kutty MS, Corea JR. Deep vein thrombosis in a jogger. Am J Sports Med 1984; 12 (02) 169
  • 12 Tao K, Davenport M. Deep venous thromboembolism in a triathlete. J Emerg Med 2010; 38 (03) 351-353
  • 13 Theiss JL, Fink ML, Gerber JP. Deep vein thrombosis in a young marathon athlete. J Orthop Sports Phys Ther 2011; 41 (12) 942-947
  • 14 Richard S, Lacour JC, Frotscher B, Enea A, Mione G, Ducrocq X. Report of a recurrent cerebral venous thrombosis in a young athlete. BMC Neurol 2014; 14: 182
  • 15 Hull CM, Hopkins CL, Purdy NJ, Lloyd RC, Harris JA. A case of unprovoked venous thromboembolism in a marathon athlete presenting atypical sequelae: what are the chances?. Scand J Med Sci Sports 2015; 25 (05) 699-705
  • 16 Sanz de la Garza M, Lopez A, Sitges M. Multiple pulmonary embolisms in a male marathon athlete: is intense endurance exercise a real thrombogenic risk?. Scand J Med Sci Sports 2017; 27 (05) 563-566
  • 17 Noakes T, Opie L, Beck W, McKechnie J, Benchimol A, Desser K. Coronary heart disease in marathon runners. Ann N Y Acad Sci 1977; 301: 593-619
  • 18 Albano AJ, Thompson PD, Kapur NK. Acute coronary thrombosis in Boston marathon runners. N Engl J Med 2012; 366 (02) 184-185
  • 19 Hull CM, Harris JA. Cardiology patient page. Venous thromboembolism and marathon athletes. Circulation 2013; 128 (25) e469-e471
  • 20 Montagnana M, Lippi G, Franchini M, Banfi G, Guidi GC. Sudden cardiac death in young athletes. Intern Med 2008; 47 (15) 1373-1378
  • 21 Chugh SS, Weiss JB. Sudden cardiac death in the older athlete. J Am Coll Cardiol 2015; 65 (05) 493-502
  • 22 Posthuma JJ, van der Meijden PE, Ten Cate H, Spronk HM. Short- and long-term exercise induced alterations in haemostasis: a review of the literature. Blood Rev 2015; 29 (03) 171-178
  • 23 Lippi G, Schena F. Run for Science (R4S): the history of a successful project of precision and laboratory medicine in sport and exercise. J Lab Precis Med 2017; 2: 11
  • 24 Salvagno GL, Astermark J, Lippi G. , et al. Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?. Haemophilia 2009; 15 (01) 290-296
  • 25 Franchini M, Marano G, Vaglio S, Catalano L, Pupella S, Liumbruno GM. The role of ABO blood type in thrombosis scoring systems. Semin Thromb Hemost 2017; 43 (05) 525-529
  • 26 Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JW. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis. Am J Clin Pathol 2005; 124 (06) 910-917
  • 27 Lippi G, Maffulli N. Biological influence of physical exercise on hemostasis. Semin Thromb Hemost 2009; 35 (03) 269-276
  • 28 Calabrò P, Gragnano F, Golia E, Grove EL. von Willebrand factor and venous thromboembolism: pathogenic link and therapeutic implications. Semin Thromb Hemost 2018; 44 (03) 249-260
  • 29 Montagnana M, Lippi G, Danese E. An Overview of Thrombophilia and Associated Laboratory Testing. Methods Mol Biol 2017; 1646: 113-135
  • 30 Thachil J, Lippi G, Favaloro EJ. D-dimer testing: laboratory aspects and current issues. Methods Mol Biol 2017; 1646: 91-104
  • 31 Lippi G, Meschi T, Borghi L. Variation of activated partial thromboplastin time according to age and sex in a large population study: analytical and clinical implications. Blood Coagul Fibrinolysis 2012; 23 (02) 177-178
  • 32 Lippi G, Salvagno GL, Ippolito L, Franchini M, Favaloro EJ. Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis 2010; 21 (05) 459-463
  • 33 Hanke AA, Staib A, Görlinger K, Perrey M, Dirkmann D, Kienbaum P. Whole blood coagulation and platelet activation in the athlete: a comparison of marathon, triathlon and long distance cycling. Eur J Med Res 2010; 15 (02) 59-65
  • 34 Cimenti C, Schlagenhauf A, Leschnik B. , et al. Low endogenous thrombin potential in trained subjects. Thromb Res 2013; 131 (06) e281-e285
  • 35 Huskens D, Roest M, Remijn JA. , et al. Strenuous exercise induces a hyperreactive rebalanced haemostatic state that is more pronounced in men. Thromb Haemost 2016; 115 (06) 1109-1119
  • 36 Hilberg T, Prasa D, Stürzebecher J, Gläser D, Schneider K, Gabriel HH. Blood coagulation and fibrinolysis after extreme short-term exercise. Thromb Res 2003; 109 (5-6): 271-277
  • 37 Griffin JH. Blood coagulation. The thrombin paradox. Nature 1995; 378 (6555): 337-338
  • 38 Ardissino D, Merlini PA, Bauer KA. , et al. Coagulation activation and long-term outcome in acute coronary syndromes. Blood 2003; 102 (08) 2731-2735
  • 39 Jenkins PV, Rawley O, Smith OP, O'Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol 2012; 157 (06) 653-663
  • 40 Martinelli I. von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Semin Hematol 2005; 42 (01) 49-55
  • 41 Menzel K, Hilberg T. Blood coagulation and fibrinolysis in healthy, untrained subjects: effects of different exercise intensities controlled by individual anaerobic threshold. Eur J Appl Physiol 2011; 111 (02) 253-260
  • 42 Rock G, Tittley P, Pipe A. Coagulation factor changes following endurance exercise. Clin J Sport Med 1997; 7 (02) 94-99
  • 43 Kamath S, Lip GY. Fibrinogen: biochemistry, epidemiology and determinants. QJM 2003; 96 (10) 711-729
  • 44 Sumann G, Fries D, Griesmacher A. , et al. Blood coagulation activation and fibrinolysis during a downhill marathon run. Blood Coagul Fibrinolysis 2007; 18 (05) 435-440
  • 45 Prisco D, Paniccia R, Bandinelli B. , et al. Evaluation of clotting and fibrinolytic activation after protracted physical exercise. Thromb Res 1998; 89 (02) 73-78
  • 46 Hilberg T, Menzel K, Wehmeier UF. Endurance training modifies exercise-induced activation of blood coagulation: RCT. Eur J Appl Physiol 2013; 113 (06) 1423-1430
  • 47 Mandalaki T, Dessypris A, Louizou C, Bossinakou I, Panayotopoulou C, Antonopoulou A. Marathon run I: effects on blood coagulation and fibrinolysis. Thromb Haemost 1977; 37 (03) 444-450
  • 48 Lin X, El-Sayed MS, Waterhouse J, Reilly T. Activation and disturbance of blood haemostasis following strenuous physical exercise. Int J Sports Med 1999; 20 (03) 149-153
  • 49 Smith JE. Effects of strenuous exercise on haemostasis. Br J Sports Med 2003; 37 (05) 433-435